Novartis Oncology Director of Finance Salaries in Baltimore, MD | Comparably
At Novartis Oncology, we are passionate about the discovery and development of innovative medicines. read more
EMPLOYEE
PARTICIPANTS
14
TOTAL
RATINGS
161

Novartis Oncology Director of Finance Salaries in Baltimore, MD

The average Novartis Oncology Director of Finance in Baltimore, MD earns an estimated $133,587 annually. Novartis Oncology's Director of Finance compensation is $28,429 less than the US average for a Director of Finance.

In Baltimore, MD, The Finance Department at Novartis Oncology earns $7,429 more on average than the Operations Department.

Last updated 3 years ago.

$30k
$74k
$117k
$159k
$350k
$600k
$133,587
Average Compensation
$133,587
avg. base

Director of Finance Salaries at Novartis Oncology

In Baltimore, MD, Directors of Finance earn $14,685 more than Accounting Managers.

Accounting Manager
$119k*
Financial Analyst
$89k*
Business Analyst
$89k*
Senior Accountant
$78k*
Accountant
$69k*
* estimated salary

Compensation at Novartis Oncology by Department

In Baltimore, MD, The Finance Department averages $7,429 more than the Operations Department, and $11,203 less than the Business Development Department

Business Development
$95,491 Avg. total comp.
+$11k
Finance
$84,288 Avg. total comp.
Operations
$76,859 Avg. total comp.
-$7k

Director of Finance Compensation by Gender (All Companies)

The average female Director of Finance at companies similar size to Novartis Oncology reported making $176,135, while the average male Director of Finance at similar sized companies reported making $188,131.

Director of Finance Compensation by Ethnicity (All Companies)

The average Asian or Pacific Islander Director of Finance at companies similar size to Novartis Oncology reported making $193,239, while the average Native American Director of Finance at similar sized companies reported making $145,000.

How Directors of Finance at Novartis Oncology Rate Their Compensation

The majority of Directors of Finance at Novartis Oncology believe they're not compensated fairly. 100% of Directors of Finance at Novartis Oncology say they receive annual bonuses, and the vast majority (83%) are satisfied with their benefits. See more compensation ratings at Novartis Oncology

×
Rate your company